| Literature DB >> 28390536 |
Tong Zhu1, Shiva Das1, Terence Z Wong2.
Abstract
Hybrid PET/MR imaging is in early development for treatment planning. This article briefly reviews research and clinical applications of PET/MR imaging in radiation oncology. With improvements in workflow, more specific tracers, and fast and robust acquisition protocols, PET/MR imaging will play an increasingly important role in better target delineation for treatment planning and have clear advantages in the evaluation of tumor response and in a better understanding of tumor heterogeneity. With advances in treatment delivery and the potential of integrating PET/MR imaging with research on radiomics for radiation oncology, quantitative and physiologic information could lead to more precise and personalized RT.Entities:
Keywords: Hybrid PET/MR imaging; MRI-based treatment planning; Normal tissue toxicity; PET tracers; Radiation therapy; Tumor heterogeneity; Tumor response
Mesh:
Year: 2017 PMID: 28390536 DOI: 10.1016/j.mric.2017.01.001
Source DB: PubMed Journal: Magn Reson Imaging Clin N Am ISSN: 1064-9689 Impact factor: 2.266